| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $43.0M | +108.4% |
| SG&A Expense | $15.9M | +181.7% |
| Operating Income | -$58.9M | -124.2% |
| Income Tax | $2K | +100.0% |
| Net Income | -$55.3M | -110.4% |
| EPS (Basic) | -$1.32 | +30.9% |
| EPS (Diluted) | -$1.32 | +30.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $251.2M | -16.9% |
| Current Assets | $257.3M | -15.4% |
| Total Assets | $266.2M | -13.2% |
| Current Liabilities | $5.7M | +57.7% |
| Total Liabilities | $8.4M | +68.3% |
| Stockholders' Equity | $257.8M | -14.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.3M | -111.8% |
| Capital Expenditures | $559K | -15.4% |
| Investing Cash Flow | -$559K | +13.3% |
| Financing Cash Flow | $632K | -99.8% |
| Free Cash Flow | -$50.8M | -108.3% |